Last reviewed · How we verify
Jiedu Yizhi Formula
Jiedu Yizhi Formula is a Small molecule drug developed by Changchun University of Chinese Medicine. It is currently in Phase 1 development.
At a glance
| Generic name | Jiedu Yizhi Formula |
|---|---|
| Sponsor | Changchun University of Chinese Medicine |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Jiedu Yizhi Formula CI brief — competitive landscape report
- Jiedu Yizhi Formula updates RSS · CI watch RSS
- Changchun University of Chinese Medicine portfolio CI
Frequently asked questions about Jiedu Yizhi Formula
What is Jiedu Yizhi Formula?
Jiedu Yizhi Formula is a Small molecule drug developed by Changchun University of Chinese Medicine.
Who makes Jiedu Yizhi Formula?
Jiedu Yizhi Formula is developed by Changchun University of Chinese Medicine (see full Changchun University of Chinese Medicine pipeline at /company/changchun-university-of-chinese-medicine).
What development phase is Jiedu Yizhi Formula in?
Jiedu Yizhi Formula is in Phase 1.
Related
- Manufacturer: Changchun University of Chinese Medicine — full pipeline
- Compare: Jiedu Yizhi Formula vs similar drugs
- Pricing: Jiedu Yizhi Formula cost, discount & access